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Objectives. To describe trends and category of disabilities caused by Buruli ulcer disease. Design. This retrospective study was set up
to quantify information on the disability trends caused by Buruli ulcer (BU) using data on patients attending BU and chronic ulcer
clinics from 2004 to 2009, at Global Evangelical Mission Hospital, Apromase. Methods. Data was retrieved from the WHO BU1
form, case registry book, surgical theatre register, and BU patients’ records book of the hospital. Disability was measured as the
incapability of patients to perform one or more daily activities due to his/her state of BU disease before treatment. Results.At o t a l
of 336 positive BU cases comprising 181 males (53.9%) were recorded of which 113 (33.6%) cases of disabilities were identiﬁed.
A mean age of 52.5 (±1.32) years was recorded. For the trend of disabilities, the year 2009 recorded the highest (N = 34, 31.0%).
The lesions were mostly located at the lower limbs (N = 65, 57.5%) region of the patients. Lesions with diameter >15cm were the
major (59.3%) category of lesions. Conclusion. Trend of disability reveals proportional increase over the years from 2004 to 2009.
Contracture at the knee and ankle joints was the commonest disability recorded.
1.Introduction
Buruliulcer(BU)isaninfectiousdiseasecausedbyMycobac-
terium ulcerans (MU), aﬀecting the skin, subcutaneous tis-
sue, and sometimes the bone. The natural reservoir of the
bacillus and the mode of transmission of the disease is
unclear [1, 2]. MU has been identiﬁed by molecular tools
from the environment and, recently, cultured; it is generally
believed to be an infection by an environmental microor-
ganism [3]. Many diﬀerent animal species appear to test
positive in endemic areas, [4–7] although, a typical vector
has not been convincingly identiﬁed [8, 9]. Aquatic insects,
notably, Naucoridae spp. may serve as a vector of MU [6].
Case control studies among people living in endemic areas
have identiﬁed risk factors to contract the disease; there is a
striking association with stagnant and slowly ﬂowing water
bodies [10–12]. This disease has emerged dramatically in
West Africa (Cˆ ote d’Ivoire, Ghana, and Benin). Prevalence
rates in endemic districts in Ghana are reported to be up to
150 per 100,000 persons [13, 14].
According to the clinical case deﬁnition of the World
Health Organization (WHO), the preulcerative stage in-
cludes nodules, plaques, or edema [2]. Few patients may
visit a hospital with this stage of the disease. The most2 Plastic Surgery International
frequent lesion is an ulcer. In the ulcerative stage, skin ulcers
with typically undermined edges can be clinically diagnosed
from other skin disorders. Later, a granulomatous healing
response occurs, and ﬁbrosis, scarring, calciﬁcation, and
contractures with permanent disabilities may result [15]. In
rural Africa, patients tend to report to the hospital late in the
course of the disease, and some long-standing and extensive
lesions that have aﬀected joints and bone may have advanced
to a stage that amputation is the only reasonable option for
these extensive lesions [16]. Indeed, with increasing patient
delay, lesions tend to become larger resulting in more
severe functional limitations [17]. In Benin, focus group
discussions revealed that people believe that this disease
may be natural, “sent directly by God,” or induced by
another person through sorcery [18]. Most interviewees
admitted that they would ﬁrst see a traditional healer
before considering treatment in a hospital. In Ghana, most
healthy respondents (without BU) said they would attend
the hospital with an ulcerative lesion but would try herbal
treatment if the lesion were a nodule; patients with BU had
admitted that they would only go to the hospital if lesions
became larger than expected [19]. Fear of surgery might
be one of the factors associated with patients’ decision to
postpone having treatment in a hospital [1].
Antibiotic treatment alone was successful in achieving a
cure in many patients, and it requires daily injections with
Streptomycin (10mg/kg body weight) and oral Rifampicin,
15mg/kg body weight. Also, a combination of chemotherapy
a n ds u r g i c a lt r e a t m e n th a db e e nr e p o r t e dt ob ee ﬀective in
the treatment of BU. Techniques used in surgical treatment
consist generally of two stages. In the ﬁrst stage the aim is
to excise all dead tissue, including a healthy tissue margin
around the lesion—typically 3-4cm [13]. This procedure
results in a large surgical lesion that needs to be skin grafted
in a second stage. Surgery involving the head and neck
region, especially the face and eyes, poses diﬃcult recon-
structive plastic surgical problems for surgeons [20–22].
Surgeryisdiﬃculttoperforminsettingswithpoorresources,
as there are very limited possibilities for general anesthesia
and blood transfusion [1]. Moreover, it requires extensive
technical and surgical skills, and the patient will undergo
several months of wound dressing, hence some expenses
will be incurred by the patient for the dressing. Finally,
with such large excisions, the wounds eventually heal at
the expense of more severe sequelae than those resulting
from less extensive surgery, conceivably resulting in more
disabilities, especially if no form of physical therapy is given
to prevent contractures.
Antibiotic treatment with Streptomycin is not an option
f o rp r e g n a n tw o m e nw h oa r et r e a t e db ys u r g e r y .P h y s i c a l
disabilities due to scar contracturemay result in psychosocial
a n de c o n o m i cp r o b l e m sa sr e p o r t e db ys o m es t u d i e s[ 19, 23,
24]. However, Lehman et al. [25] reported that the 6th WHO
Advisory Committee on Buruli ulcer recommended directly
observed treatment with the combination of Rifampicin and
Streptomycin, administered daily for 8 weeks. The study of
Chauty et al. [26] concludes that the WHO-recommended
Streptomycin-Rifampicin combination is highly eﬃcacious
for treating M. ulcerans disease.
This retrospective study was carried out to describe the
trendsandcategoryofthedisabilityandthebodypartsmost-
ly involved in deformities caused by BU disease among
patients who visited Global Evangelical Mission Hospital
(GEMH)atApromaseintheEjisu-JuabenMunicipal,Ashan-
ti Region, Ghana, from 2004 to 2009.
2.MaterialsandMethods
2.1. Study Setting. Ejisu-Juaben municipal stretches over an
area of 637.2km2 constituting about 10% of the entire
Ashanti Region and with Ejisu as its capital. The Municipal
is located in the central part of the Ashanti Region. Patients
come from the entire surrounding districts to seek BU
treatment at GEMH.
The population of the Municipality is about 120,896,
with a male to female ratio of 1:08. Children (0–14 years)
and individuals aged over 60 years form about 16.5 and 5.6
percent of the total population, respectively. The municipal
is divided into ﬁve zones, namely, Ejisu, Juaben, Achiasi,
Bomfa and Kwaso submunicipals. Bomfa (which is a town
in the Bomfa submunicipal) is a BU disease endemic area
[17, 27] located about 36km southeast of Ejisu. It is also
about 10km southwest of Konongo, which is the district
capital of the nearby Ashanti-Akim North District. There are
four primary health care facilities in Bomfa sub-municipal
and its environs, namely Bomfa Health Centre at Bomfa,
Agyenkwa Clinic at Hwereso, the Adventist (SDA) Clinic at
Nobewam,andHuttelHealthCentreatBuamadumase;these
facilities do not yet have the infrastructure to diagnose and
treat BU and so refer their BU patients to GEMH, which is in
the nearby Ejisu submunicipal.
2.2. Treatment Center. The Global Evangelical Mission Hos-
pital is located at Apromase in the Ejisu submunicipal, a
village about 10km southwest of Ejisu and also about 12km
southeast of Kumasi. The hospital has thirty-ﬁve beds. It is
owned by the Global Evangelical Church with its headquar-
ters in Accra, the capital city of Ghana.
2.3. Data Acquisition. Disability was measured in the study
as the incapability of patients to perform one or more daily
activities due to his/her state of BU disease before treatment
at GEMH. Thus, patients whose stage of BU disease when
reported for treatment at GEMH had aﬀected their daily
activities were considered as disabled in the study.
BU cases were diagnosed in this study by the conﬁrma-
tion by any two positive of Ziehl-Neelson (ZN) test for acid
fast bacilli, polymerase chain reaction (PCR), and histopa-
thology. BU patients whose records ﬁtted in the category of
the study were selected.
Information on patients attending BU and chronic ulcer
clinics at GEMH from 2004 to 2009 was utilized for the
study. Ethical approval for the study was obtained from
the Ethical Committee of the School of Medical Sciences,
Kwame Nkrumah University of Science and Technology,
Kumasi.DataforthestudywasretrievedfromtheWHOBU1
forms, case registry book, surgical theater register, and BU
patients’ records book of the hospital. Data obtained includePlastic Surgery International 3
demographic features of patients, laboratory investigations,
and category and location of lesion(s). Data obtained was
recorded, analyzed, and displayed in tables and graphs using
SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA).
2.4.ClinicalDiagnosis. DiagnosisofBUwasbasedonclinical
ﬁndings such as chronicity of the wound, typical under-
mined edges with central necrotic tissues, and failure to
respond to traditional wound management procedures and
antibiotic therapy. The ﬁndings were then conﬁrmed by any
two positive of ZN test for acid fast bacilli, PCR, and
histopathology.
2.5. Patients Management. According to current WHO
guidelines, BU treatment should be surgery combined with
chemotherapy (a combination of Rifampicin and Strepto-
mycin/Amikacin for 8 weeks as a ﬁrst-line treatment) and
physiotherapy [25, 27]. All patients had antibiotics (Strep-
tomycin and Rifampicin for 8 weeks); patients without con-
traindication for antibiotic treatment (e.g., pregnancy) were
treated with Streptomycin and Rifampicin daily. Patients
with ulcers had debridement and skin grafting. Some of
them, because of the location of the ulcers (immediately
adjacent to the eye), could not have complete excision. They
were dressed over long periods with normal saline or 2%
aceticacidlotions.Becauseofthediﬃcultyinachievinggood
hemostasis, some of the excised ulcers were grafted secon-
darily within 48–72 hours or a week later. Some recurrent
ulcerated cases at diﬀerent anatomic parts of the body were
conﬁrmed positive by both ZN and PCR techniques. There
was no sign of antibiotic resistance, and the lesions were
treated with the combination of surgery and chemotherapy.
3. Results
Information on 864 patients was retrieved, out of which 336
positiveBUcasescomposedofmoremales(N = 181,53.9%)
than females (N = 155, 46.1%) were recorded during the
study period. All stages (preulcer, ulcer, and healing stages)
of the disease were identiﬁed, with the ulcer stage being
the dominant (N = 248, 73.8%) followed by healing stage
(N = 79, 23.5%). It was also noted that all the patients who
had a disability were those from the ulcer stage. Again, the
majority (62.2%) of the study patients resided in the Ejisu-
Juaben Municipality.
In terms of disabilities, out of the 336 positive BU pa-
tients who patronized the facility, 113 developed disabilities
at diﬀerent parts of their bodies. The ages of the BU disabled
patients cut across all the age groups (a mean age of 52.5
(±1.32) years), with the bulk of them falling within 60–74
years followed by 0–14 years old children (Figure 1).
Each patient was taken through the three laboratory
investigations. The laboratory report (ZN, culture, PCR, and
histopathology) of the 336 patients revealed that PCR and
histopathology recorded the highest sensitivity as compared
to the other tests. Table 1 shows the age groups of patients
againstthenumberofBUpatientswhotestedpositiveineach
laboratory investigation.
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Figure 2: Trend of Buruli Ulcer cases and functional disabilities.
Table 1:DistributionoflaboratoryconﬁrmationoftheBuruliulcer
patients (N = 336).
Laboratory test
Age ZN Culture PCR Histopathology
0–14 33 48 63 63
15–29 21 27 45 45
30–44 21 30 42 42
45–59 18 21 27 27
60–74 57 66 102 101
75+ 27 45 57 57
Total 177 237 336 335
The trend of BU cases and disabilities was found to be
increasing from 2004 to 2009, with the year 2008 having the
highest BU cases (N = 97, 28.9%). In terms of percentage
disability, 2007 recorded 22.5% and 2008 recorded 29.9%,
while 2009 registered 31.0% (Figure 2).
The contractures were mostly located at the lower limbs
(N = 65, 57.5%), with few (6.2%) located in the head and
neck region (HNR) of the patients (Table 2).
Representations of these locations are shown in Figures
3, 4,a n d5.4 Plastic Surgery International
Table 2: Location and distribution of Buruli ulcer sequelae on
patients (N = 113).
Location of sequelae Frequency (%)
Lower extremity contracture 56 (49.6)
Upper extremity contracture 38 (33.7)
Amputation within the lower extremities 9 (8.0)
Amputation within the upper extremities 3 (2.6)
Loss of eye (s) 2 (1.7)
Loss of eyelids 4 (3.5)
Loss of nose (or part of it) 1 (0.9)
Figure 3: Buruli Ulcer Sequelae of the face.
Figure 4: Shoulder joint contracture caused by Buruli ulcer.
The category of lesions had been classiﬁed into three
(3) groups according to WHO [25]. Category (CAT) 1 is
for single lesion <5cm in diameter, CAT 2 for single lesion
5–15cm in diameter, and CAT 3 > 15cm for single or
multiple lesions at critical sites such as the joints and others
may be osteomyelitis. The CAT 3 lesions were identiﬁed to
contribute mostly (N = 69, 61.1%) in the BU disability
development (Figure 6).
Figure 5: Wrist contracture of the left hand caused by Buruli ulcer.
CAT 1
CAT 2
CAT 3
2.6%, N = 3
36.3%, N = 41
61.1%, N = 69
Figure 6: A chart showing the distribution of the categories of
lesions.
4. Discussion
In our study, patients who developed sequelae were those
who do not come to the hospital until the ulcerative stage
of disease. Out of the 336 positive BU cases 113 (33.6%)
developed disabilities. A similar study in Cˆ ote D’Ivoire
recorded 82 (26.0%) of patients with healed ulcers who had
chronic disability [27]. Age is an important demographic
factor in terms of BUD, and a lot of studies had shown
that children (0–14 years) are the most vulnerable, while
genderisinsigniﬁcant[27].However,concerningdisabilities,
Stienstra et al. (2005) reported that, increased age and female
sex were independent risk factors for functional limitation
[28]. The results of our study reveal that most of the BU
disabled individuals were adults (Figure 1). Our ﬁndings
buttress that of Stienstra et al. (2005), and the reason for
this alternation in age groups in terms of BU infection and
disability may be ignorant of the preulcerative stage of the
disease by most adults, believing that this disease may be
natural,“sentdirectlybyGod,”orinducedbyanotherperson
through sorcery [18]. Trying herbal treatment [29] and the
fear of surgery might be one of the factors associated with
patients’ decision to postpone having treatment in a hospital
[1].Plastic Surgery International 5
AcombinationofRifampicinandStreptomycinadminis-
tered daily for 8 weeks had been reported to be very eﬀective
in the management of BUD [25]. However, in this study, few
patientshadarecurrentBUD.ThestudyofO’Brienetal.[30]
and that of Ruf et al. [31] reveal that most lesions appearing
during or after antibiotics treatment are due to paradoxical
reaction, and this will be the case in our study, since the
cultured specimen recorded no growth, despite ZN and PCR
being positive.
Buruli ulcer disabilities were also identiﬁed to have a rel-
atively direct increasing pattern with the study years (Figure
2). This trend which is illustrated graphically may have been
inﬂuencedbyfactorssuchashealtheducationandpopularity
of GEMH in terms of management of BU patients. The
hospital started treatment of BU cases in July 2004, this
is revealed in the least number of cases recorded (Figure
2). Although the BU cases were minimal, a relatively high
number (60%) of them developed disabilities. The following
three years (i.e., 2005–2007) were backed by a strong health
education team to create awareness and educate the public
on BUD in the district and environs. This health education
programcontributedalot;patientswhohadbeenrejectedby
their families due to the belief that they had been cursed and
others with long futile herbal medications had hope at last.
This situation faced by the BU patients had been conﬁrmed
in earlier studies by Aujoulat et al. [18] and Stienstra et
al. [19]. The number of BU disabilities recorded dropped,
even though there was a slight increase of BU cases towards
2007. The reason for this decrease in disabilities may be as a
result of the health education, since most of the cases within
those years were in the preulcerative stage. This fact has
already been suggested by Lehman et al. in BU prevention of
disabilityforWHO[25].Furthermore,thesuddenescalation
of both BU cases and disabilities for the other two years
(i.e., 2008 and 2009) may be due to the popularity of the
hospital in terms of BU treatment and patient management,
since most of the patients treated within those years were
patientswhohadbeenreferredfromdiﬀerenthospitalsinthe
region and beyond with large chronic ulcers (Figure 6;T a b l e
1). Most of these patients developed various disabilities and
horrible scars—leading to limited eye closure, limited exten-
sion and ﬂexion of muscles, limited knee extension and foot
dorsiﬂexion,deviationofthehandandfoot,amongothers—
which may also aﬀect them psychologically and socially [25].
Earlier studies had reported that lesions at a joint are
associated with increased risk for residual functional limi-
tations [29, 32, 33]. Furthermore, amputation and visible
muscular atrophy were associated with increased chance of
residualfunctionallimitationsinpreviousstudies[1,28,32].
Nonhealedlesionsandalesionatadistalpartofanextremity
were among independent risk factors for functional limi-
tation in an earlier study [28]. Ellen et al. [24] in their
assessment of functional limitation caused by BUD reported
that out of 78 BU patients 58% had a reduction in the
range of motion of one or more joints, 30% had one or
more functional limitations of the leg and 21% of the arm,
49% had a functional limitation. The ﬁndings of our study
were similar to the previously mentioned studies. Lesions at
joints and the extremities of limbs were prone to disabilities
due to the development of contractures or amputations
(Table 2). Although disabilities such as visual impairment
and psychological eﬀects due to facial scars associated with
the head and neck region of BU patients (Figure 3)w e r e
relatively few in our study, the level of disaster caused is
equally severe, since the individual is incapacitated in almost
all aspects of life, even in formal education especially when
the victim is a child [21, 25].
Barogui et al. [1] in their study reported that a lesion
>15cm had the highest percentage of patients with func-
tional limitation. Debacker et al. [34] in a Benin study
reported that a year after the introduction of antibiotic
treatment to all patients with Buruli ulcer in Benin, the
number of small (category I) lesions (<5cm)atpresentation
increased while the number of large (>15cm; category III)
lesions decreased. He added that “it might reﬂect earlier
reporting,perhapsasaresultoftheintroductionofantibiotic
treatment or of patient education”. The results of this current
study reveal that most of the lesions had a diameter >15cm;
lesion <5cm were located around the eye region (Figure 6).
This is practically the same as that of Barogui et al. [1],
however, not in line with the report of Debacker et al. [34].
Thismightbeduetothedelayinseekingappropriatemedical
treatment by most of the patients, hence, report to GEMH
with already deteriorated BU conditions.
AsadvocatedbyWHOin“Conceptsinpreventionofdis-
ability and rehabilitation”, disability in BU can be prevented
or minimized with early diagnosis of the nodules, antibiotic
treatment, and surgical excision—together with adequate
management of the skin, soft tissues, and joints during the
wound-healing process [25]. In addition it should be noted
that intervention to prevent disability start before excision
and continue after excision and skin grafting, in order to
prevent soft tissue and joint contractures. Prevention of
disability and rehabilitation are only possible with the active
participation of those aﬀected by BU, their families, the
community, and the health-care team.
5. Conclusion
The trend of disability after the study reveals a proportional
increase from 2004 to 2009. Contracture at the knee and
ankle joint after healing was the highest disability recorded.
Management diﬃculties and disabilities caused by BUD
could be avoided by early detection and treatment of the
disease, supported by intensive health education programs
within the municipality and its environs.
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